ClearMed
BriefingsDrug & Biomarker IndexSaved (0)
All Nephrology BriefingsJAMA
NephrologyReal-World Cohort2 min read

SGLT2 Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From Kidney Week

SGLT2 Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From investigated in a observational cohort study at JAMA.

Published in JAMAObservational cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

This Medical News article is an interview with Keisha Gibson, MD, MPH, cochair of the Kidney Week Education Committee and chief of pediatric nephrology at the University of North Carolina at Chapel Hill.

What Changes?

Nephrology · Real-World Cohort

Current Standard

Conventional nephrology practice relies on standard-of-care monitoring and existing regimens prior to this study.

New Finding

Published in JAMA, these peer-reviewed nephrology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Built around Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From, this strategy modulates glomerular filtration & renal tubular preservation.

  2. 02Study Evidence

    Tested in a study at the real-world stage.

  3. 03Practical Meaning

    findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

Published in JAMA, these peer-reviewed nephrology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

The Discovery

This Medical News article is an interview with Keisha Gibson, MD, MPH, cochair of the Kidney Week Education Committee and chief of pediatric nephrology at the University of North Carolina at Chapel Hill.

How It Works, Simply

This nephrology research focuses on glomerular filtration & renal tubular preservation. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Built around Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From, this strategy modulates glomerular filtration & renal tubular preservation.

  2. 02Study Evidence

    Tested in a study at the real-world stage.

  3. 03Practical Meaning

    findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study

Observational cohort study · Real-World Cohort

Biological Pathway & Modality

Glomerular filtration & renal tubular preservation

Intervention: Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From

02

Experimental Findings & Endpoints

This Medical News article is an interview with Keisha Gibson, MD, MPH, cochair of the Kidney Week Education Committee and chief of pediatric nephrology at the University of North Carolina at Chapel Hill.

03

Clinical Translation & Practice Context

Published in JAMA, these peer-reviewed nephrology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

03

The Bottom Line · Clinical Pearl

“This Medical News article is an interview with Keisha Gibson, MD, MPH, cochair of the Kidney Week Education Committee and chief of pediatric nephrology at the University of North Carolina at Chapel Hill.”

Published in JAMA · Current Stage: Real-World Cohort

Practical Next Step

Questions for Your Next Doctor Visit

  1. 1Based on my health history, do these nephrology findings (observational cohort study in nephrology care) apply to my situation?
  2. 2How do the potential benefits of this approach compare with the standard care I'm currently using?
  3. 3Given the study's key limitation (observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.), what risks or follow-up steps should we watch for?
Nephrology · Real-World Cohort
Study Type
Observational cohort study

Observational cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study in nephrology care
Intervention & Mechanism
SGLT2 Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From

Glomerular filtration & renal tubular preservation

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

SGLT2 Inhibitors

Original Publication & AMA Citation

SGLT2 Inhibitors, Potassium Binders, Pregnancy After Kidney Donation, and More From Kidney Week. JAMA. Published 2026;Nov 6. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42993529/

JAMA

https://pubmed.ncbi.nlm.nih.gov/42993529/

Read Original Paper

Continue Reading

Related in Nephrology

View all Nephrology briefings →
NEPHROLOGY · PRECLINICAL

Gut-targeted interventions to complement PTH-lowering therapy

These findings highlight the potential of gut-targeted interventions to complement established parathyroid hormone-lowering strategies for improving skeletal health. Secondary hyperparathyroidism is a major contributor to skeletal fragility in chronic kidney disease, yet fracture risk remains high despite parathyroid hormone-lowering therapy.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readKidney International
NEPHROLOGY · PHASE I/II

Fingerprinting the polycystic kidney: radiomics of the noncystic parenchyma for earlier ADPKD detection

Small, cross-sectional, unmatched data require longitudinal validation of reproducibility, prognostic value, and clinical utility. Autosomal dominant polycystic kidney disease risk stratification relies on total kidney volume, a validated marker of cyst burden and progression.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readKidney International
NEPHROLOGY · CLINICAL PRACTICE

Kidney stone disease: to drink or not to drink-that is the question

Effective prevention likely requires achieving a substantial increase in urine volume alongside comprehensive dietary and pharmacologic management. An important point to note is that these findings do not invalidate the protective role of increased urine volume but highlight the limitations of behavioral interventions alone.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readKidney International